Critical Sized Defect
Critical Sized Defect - Related Videos
09:41
A Simple Critical-sized Femoral Defect Model in Mice
0 Views •
Cited by 17 •
2015
Animal models are frequently employed to mimic serious bone injury in biomedical research. Due to their small size, establishment of stabilized bone lesions in mice are beyond the capabilities of most research groups. Herein, we describe a simple method for establishing and analyzing experimental femoral defects in mice.
06:38
Establishment of a Segmental Femoral Critical-size Defect Model in Mice Stabilized by Plate Osteosynthesis
0 Views •
Cited by 12 •
2016
Although mouse models are invaluable tools for bone tissue engineering, models of long bone defects are sparse. This need motivated development of the present protocol which uses a locking plate with four screws and a dedicated jig to perform and stabilize a reproducible, femoral, critical-size defect with low morbidity.
11:31
Repair of a Critical-sized Calvarial Defect Model Using Adipose-derived Stromal Cells Harvested from Lipoaspirate
0 Views •
Cited by 21 •
2012
This protocol describes the isolation of adipose-derived stromal cells from lipoaspirate and the creation of a 4 mm critical-sized calvarial defect to evaluate skeletal regeneration.
07:35
Creating Rigidly Stabilized Fractures for Assessing Intramembranous Ossification, Distraction Osteogenesis, or Healing of Critical Sized Defects
0 Views •
Cited by 20 •
2012
This article describes a method for stabilizing long bone fractures that is based on the application of modified Ilizarov external fixators 1-3. After application of the fixators and creation of the bone injury, healing can be assessed, distraction osteogenesis can be performed, or non-union or critical sized defect can be created and used to study therapeutic interventions.
08:39
Longitudinal Micro-Computed Tomography Image Analysis for User-Defined Region of Interest in Critical-Sized Bone Defects
0 Views •
Cited by 1 •
2025
We present a method for analyzing a user-defined region of interest (ROI) in a longitudinal in vivo rat radial defect model. This method enables comparative analysis between different scaffolds previously limited by variations in microcomputed tomography (µCT) scan field of view, specimen orientation, and baseline presence of scaffold.
FAQs
These variables determine whether new tissue can bridge the injury and restore structural continuity. A larger gap may be more difficult to repair, while location can affect the surrounding healing context. Biological conditions also influence the body’s repair capacity. Considering all three factors helps researchers interpret persistent nonunion and compare therapeutic strategies fairly.
Persistent nonunion shows that spontaneous repair has not restored the damaged structure. This outcome provides a clear basis for testing whether a graft, biomaterial, scaffold, or regenerative strategy improves healing. By examining whether tissue bridges the defect and structural repair progresses, researchers can distinguish promising interventions from approaches that do not overcome impaired healing.
Studies commonly examine new tissue integration, vascularization, and mechanical restoration. Integration indicates whether the developing tissue connects appropriately with the surrounding repair site, while vascularization reflects blood-vessel development within the healing region. Mechanical restoration addresses recovery of structural function. Together, these measures provide complementary evidence about the quality and completeness of repair.
Standardized models create a consistent injury framework for evaluating different grafts, biomaterials, scaffolds, and regenerative medicine strategies. Researchers can compare how each intervention affects tissue bridging, integration, vascularization, mechanical restoration, and overall healing. This consistency strengthens interpretation because differences in outcomes are more directly associated with the treatment rather than an uncontrolled defect condition.
The general approach is to establish a defined tissue injury, apply the therapeutic intervention, and assess healing against the relevant repair outcome. Evaluation may include tissue integration, vascularization, mechanical restoration, and evidence of bridging across the defect. This workflow allows researchers to determine whether the tested strategy improves structural repair beyond the impaired baseline.
These models are particularly relevant when substantial tissue loss occurs after trauma, tumor resection, infection, or other damaging conditions. Such clinical situations may leave defects that require more than routine spontaneous repair. Testing treatments in these models helps guide development of grafts, scaffolds, biomaterials, and regenerative approaches intended to improve reconstruction and healing.